Asia · Regional markets · CNBC-TV18
Here's why Granules India shares could see a reaction on Monday
Granules India reported that the US FDA issued Form 483 with 11 observations for its Hyderabad facility following a GMP inspection.
Read the full article on CNBC-TV18 Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

